Recent research studies evidenced that the expression of TRIB3 could be upregulated in a number of cancers, such as breast cancer, colorectal cancer, and lung cancer (Wennemers et al., 2011; Yu et al., 2019; Yu et al., 2020). This evidence concerns the gene TRIB3 and breast carcinoma.